# ClinicalTrials.gov record NCT07531251

> PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was elamipretide.

- Evidence object: `story:clinicaltrials-gov-nct07531251-elamipretide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-13
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07531251-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07531251-elamipretide-v1.json
- Content SHA-256: `2137907cbed70fb440f8916dfd88accde8cabb619e7bdebfdcac9d4b7a0a0ef5`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07531251 ([`ctg-observation-nct07531251-2026-07-13-a3abd3798f6f`](#source-ctg-observation-nct07531251-2026-07-13-a3abd3798f6f))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was elamipretide. ([`ctg-observation-nct07531251-2026-07-13-a3abd3798f6f`](#source-ctg-observation-nct07531251-2026-07-13-a3abd3798f6f))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-08-10T18:10:04.223Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was elamipretide. ([`ctg-observation-nct07531251-2026-07-13-a3abd3798f6f`](#source-ctg-observation-nct07531251-2026-07-13-a3abd3798f6f))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07531251-2026-07-13-a3abd3798f6f`](#source-ctg-observation-nct07531251-2026-07-13-a3abd3798f6f))

## Sources

<a id="source-ctg-observation-nct07531251-2026-07-13-a3abd3798f6f"></a>
- **ClinicalTrials.gov record NCT07531251 · retained source version 2026-07-13:a3abd3798f6f0dcd17555c9da0b3347859e9f47c7f7f691e6cc9870654fd9f5a** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07531251) (`ctg-observation-nct07531251-2026-07-13-a3abd3798f6f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07531251." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07531251-elamipretide-v1.json SHA-256: 2137907cbed70fb440f8916dfd88accde8cabb619e7bdebfdcac9d4b7a0a0ef5.